Glenohumeral Cortisone Injection
- Registration Number
- NCT04216017
- Lead Sponsor
- University of Washington
- Brief Summary
The objective of this project is to determine if giving a cortisone injection to patients with proximal humerus fractures who have stiff shoulders recover their range of motion.
- Detailed Description
THis is a randomized control trial to determine if giving a cortisone injection to patients with proximal humerus fractures who have stiff shoulders recover their range of motion.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 9
1.18-90
-
Proximal Humerus Fracture
-
Decreased range of motion at 6 wk follow-up
-
Likely to be available for follow up for 26 wks
- Known drug allergy to kenalog or lidocaine
- Unable to complete functional outcome
- Pregnant Women
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Controls Lidocaine Patients receiving lidocaine Cases kenalog Patients receiving Kenalog
- Primary Outcome Measures
Name Time Method American Shoulder Elbow Society Score 24 weeks Outcome Instrument high is good low is bad 0-100 The ASES is a condition-specific scale that is intended to measure functional limitations and pain of the shoulder.
- Secondary Outcome Measures
Name Time Method Visual Analogue Scale 24 weeks pain scale - high is bad - low is good 0-100
Trial Locations
- Locations (1)
University of Washington
🇺🇸Seattle, Washington, United States